Announcements Trials
Browse Landscape

Phase

Phase 4 6Phase 2 2Phase NA 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Lymphoma 3Leukemia 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Small Cell Lung Carcinoma 1Rare Tumour 1Neoplasms, Germ Cell and Embryonal 1Lymphoma, Mantle-Cell 1

Interventions

Cyclophosphamide 192Methotrexate 106Cytarabine 86fludarabine phosphate 80Busulfan 71Tacrolimus 70Peripheral Blood Stem Cell Transplantation 69Mycophenolic Acid 69Whole-Body Irradiation 68Vincristine 67fludarabine 61Filgrastim 61Etoposide 59Dexamethasone 54Melphalan 52Radiotherapy 47Rituximab 46Cyclosporine 46Doxorubicin 38Antilymphocyte Serum 37Thiotepa 35Prednisone 35Mercaptopurine 35Granulocyte Colony-Stimulating Factor 35blinatumomab 33pegaspargase 27Methylprednisolone 27Daunorubicin 26Clofarabine 26Asparaginase 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Teniposide × Clear all
NCT00186875 2017-07-28

Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia

St. Jude Children's Research Hospital

Phase 2 Completed
47 enrolled 10 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00184041 2014-05-22

Intensified Post Remission Therapy Containing PEG-Asparaginase

University of Southern California

Phase 2 Completed
47 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡